Company Profile

Welcome to Fazheluo Bio

Welcome to Fazheluo Bio, we are at the forefront of life sciences and working together to create a healthier and more sustainable world.

Since its founding in 2013, Fazheluo Bio has been deeply rooted in the life sciences and is a high-tech enterprise driven by technological innovation. The company's headquarters and R&D center are located in Hangzhou. The core R&D team brings together the elite of the world's top universities and research institutions from China, Germany, Switzerland, the United States, India and other countries. The proportion of master's degree and above is as high as 70%. For more than a decade, we have established a complete life science R&D and synthetic biotechnology platform, committed to providing high-quality medical and health products and comprehensive solutions to customers around the world through cutting-edge synthetic biology and green chemical processes.

Relying on its strong technical heritage, Fazheluo has built a diversified and high-value-added product matrix that fully empowers multiple core industries.

In the field of bio-based materials and chemicals, we comply with the trend of green and sustainable development, and vigorously promote the research and development and market-oriented application of new bio-based materials and monomers. Combined with our deep accumulation in the field of fine chemicals, the company provides customers with high-quality chemicals and new organic active materials to help the green upgrading of the downstream industry.

In agriculture and animal health, Fazheluo relies on its technical advantages in biochemicals and fine chemicals to actively explore and develop related innovative products and is committed to safeguarding modern agriculture and animal health.

In the field of pharmaceutical core raw materials, we are a trusted professional supplier in the industry. The company focuses on the customized development and large-scale production of high-end pharmaceutical intermediates, and follows the global wave of biomedical innovation, becoming a key raw material for small nucleic acid drugs and a key supplier of anti-tumor and neurological drugs. With advanced preparation technology and strict quality control system, we have successfully broken through a number of technical bottlenecks, providing a strong supply chain guarantee for the R&D and production of downstream innovative pharmaceutical companies.

In the field of general health and nutrition, we integrate rigorous pharmaceutical-grade standards into daily health care. The company's independently developed "Fazheluoglucosamine glucosamine chondroitin calcium tablets" have been officially approved by "Blue Hat health food approval" in 2026, providing the public with safe and efficient bone and joint health solutions. At the same time, we actively expand the food and health food sectors, and are committed to improving the quality of human life and protecting the vitality of the public.

Adhering to the concept of "technology leads health", we will continue to make two-way efforts in multi-dimensional industries such as pharmaceutical raw materials, general health, new materials, agriculture and animal health, empower industry development with solid scientific research strength, and create a better life together.